| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | WO1999051735A3 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 04/12/2001 | DE19949043A1 Suppositories used for treating acute and chronic pain contain tramadol and diclofenac |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | DE19948129A1 Wirkstoffkombinationen mit insektiziden und akariziden Eigenschaften Drug combinations with insecticidal and acaricidal properties |
| 04/12/2001 | DE19948126A1 Pharmazeutisches Mittel zur Behandlung von Kachexie und/oder kardiogenem Schock A pharmaceutical composition for the treatment of cachexia and / or cardiogenic shock |
| 04/12/2001 | DE19947747A1 Treatment of urinary incontinence using (+)-tramadol, O-demethyl-tramadol or O-demethyl-N-mono-desmethyl-tramadol, having strong effect on bladder function without side-effects or analgesic action |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2387288A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386517A1 Amine derivatives |
| 04/12/2001 | CA2386513A1 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386419A1 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386381A1 Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386373A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 04/12/2001 | CA2386360A1 Active ingredient combinations having insecticidal and acaricidal properties |
| 04/12/2001 | CA2386277A1 An improved pharmaceutical composition and a process for its preparation |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386157A1 Amide compounds |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2386036A1 Antiobesity agent |
| 04/12/2001 | CA2386030A1 Integrin receptor antagonists |
| 04/12/2001 | CA2386007A1 System and device for preventing restenosis in body vessels |
| 04/12/2001 | CA2385961A1 Agents for reducing cholesterol-uptake and liquid-uptake |
| 04/12/2001 | CA2385930A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | CA2385853A1 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2383836A1 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 04/12/2001 | CA2383306A1 Novel pharmaceutical compositions |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379971A1 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2372715A1 Preventive or therapeutic drugs for diabetes |
| 04/12/2001 | CA2354043A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | CA2350715A1 A method for the treatment of ocular oxidative stress |
| 04/12/2001 | CA2322936A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive nuclide |
| 04/11/2001 | EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090985A1 Feline-derived T-cells |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090920A1 Cephem compounds |
| 04/11/2001 | EP1090919A1 Fine powder of l-alpha-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders |
| 04/11/2001 | EP1090917A1 Quinolin-4-yl derivatives and their use as NMDA-receptor subtype blockers |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1090668A1 Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter |
| 04/11/2001 | EP1090644A2 Combination effective for the treatment of impotence comprising a potassium-channel-opener and a cGMP elevator |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090638A1 Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090636A1 High lipid diet |
| 04/11/2001 | EP1090635A2 Use of ferulic acid for treating hypertension |
| 04/11/2001 | EP1090634A1 Agents for reducing cholesterol and lipid uptake |
| 04/11/2001 | EP1090630A1 Skin normalizing agents |
| 04/11/2001 | EP1090629A1 Aescin and dextran sulfate association |
| 04/11/2001 | EP1090146A1 Uses of dna-pk |
| 04/11/2001 | EP1090136A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 04/11/2001 | EP1090123A2 Polyketides and their synthesis |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090114A2 Structured antisense nucleic acid molecules |
| 04/11/2001 | EP1090110A2 Human vault rna |
| 04/11/2001 | EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 04/11/2001 | EP1090029A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090028A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1090023A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090021A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090020A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090018A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 04/11/2001 | EP1090017A1 NOVEL COMPOUNDS DERIVED FROM $g(a)-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1090013A1 Propenyl cephalosporin derivatives |